Barcelona Institute for Global Health — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Barcelona Institute for Global Health appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

15 shown

Questioning the Epidemiology of Asymptomatic TBNCT07312266 · lead sponsor · 2025-08-11

COPD Exacerbation Modelling Using Unobtrusive Sensors - the TOLIFE Clinical Study ANCT06172712 · lead sponsor · 2024-05-08

Delivering a Multi-disease Screening Tool to Migrant PopulationsNCT05868005 · lead sponsor · 2024-01-01

Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIVNCT05047315 · lead sponsor · 2021-12-01

Improving Maternal heAlth by Reducing Malaria in African HIV WomenNCT03671109 · lead sponsor · 2019-09-18

Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)NCT01388218 · lead sponsor · 2011-07-01

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early ChildhoodNCT03274739 · lead sponsor · 2004-02-01

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental ComplicationsNCT07356817 · collaborator · 2023-08-28

Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life (2)NCT07655141 · collaborator · 2027-01-01

NOT_YET_RECRUITING

META Trial - a Mixed Methods Process EvaluationNCT06743698 · collaborator · 2025-06-01

NOT_YET_RECRUITING

TB-CAPT EXULTANT - HIVNCT04568967 · collaborator · 2022-09-05

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsNCT06688149 · collaborator · 2021-01-31

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe PneumoniaNCT03915366 · collaborator · 2020-03-01

Determinants of Onset and Progression of COPD in Young AdultsNCT02352220 · collaborator · 2015-01-01

Impact of "Telecoaching Program" on Physical Activity in Patients With COPDNCT02158065 · collaborator · 2014-05-01

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Barcelona Institute for Global Health as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo Oral Tablet1

valganciclovir Oral Solution [Valcyte]1

placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial valganciclovir Oral Solution [Valcyte] RxCUI 863561 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator8

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.